# Long-term Study of Ciclosporin for Atopic Dermatitis

> **NCT00232063** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Severe Atopic Dermatitis

## Interventions

- **DRUG:** ciclosporin

## Key facts

- **NCT ID:** NCT00232063
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-11
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232063, "Long-term Study of Ciclosporin for Atopic Dermatitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00232063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*